|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM365787922 |
| 003 |
DE-627 |
| 005 |
20240315232941.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202308110
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1330.xml
|
| 035 |
|
|
|a (DE-627)NLM365787922
|
| 035 |
|
|
|a (NLM)38088059
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Wang, Lingtian
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Biomimetic Targeting Nanoadjuvants for Sonodynamic and Chronological Multi-Immunotherapy against Holistic Biofilm-Related Infections
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 15.03.2024
|
| 500 |
|
|
|a Date Revised 15.03.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2023 Wiley-VCH GmbH.
|
| 520 |
|
|
|a Biofilm-related infections (BRIs) present significant challenges owing to drug resistance, adverse immune responses, and implant failure; however, current approaches inadequately cater to the diverse therapeutic requirements at different stages of infection. To address this issue, a multi-immunotherapy strategy in combination with sonodynamic therapy is proposed for the chronological treatment of BRIs. Macrophage membrane-decorated targeting sonosensitive nanoadjuvants are fabricated to load cytosine-phosphate-guanine oligodeoxynucleotide (CPG-ODN) or microRNA (miR)-21-5p. In the early stages of BRI (Stage I), CPG-ODN-loaded nanoadjuvants (CPGHMPN@M) promote the formation of neutrophil extracellular traps to capture and neutralize detached microbes. During the late stage of infection (Stage II), CPG-ODNs redirect macrophage polarization into the M1 phase to combat infections via TLR9/Myd88/TRAF6 pathway. During these stages, CPG@HMPN@M generates singlet oxygen through sonodynamic processes, eradicating the biofilms under US irradiation. Once the BRIs are eliminated, miR-21-5p-loaded nanoadjuvants (miR@HMPN@M) are delivered to the lesions to suppress excessive inflammation and promote tissue integration by evoking macrophage M2 polarization during the repair phase (Stage III) through PTEN/PI3K/Akt pathway. This innovative approach aims to provide comprehensive treatment strategies for the chronological treatment of BRI by effectively eliminating infections, promoting tissue restoration, and implementing different immune regulations at different stages, thus demonstrating promising clinical value
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a biofilm-related infections
|
| 650 |
|
4 |
|a chronological multi-immunotherapy
|
| 650 |
|
4 |
|a macrophage polarization
|
| 650 |
|
4 |
|a nanoadjuvant
|
| 650 |
|
4 |
|a sonodynamic therapy
|
| 650 |
|
7 |
|a Phosphatidylinositol 3-Kinases
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.1.-
|2 NLM
|
| 650 |
|
7 |
|a MicroRNAs
|2 NLM
|
| 700 |
1 |
|
|a Zhang, Changqing
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhao, Jinhui
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhu, Ziyang
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Jiaxing
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Fan, Wenpei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jia, Weitao
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 11 vom: 15. März, Seite e2308110
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:11
|g day:15
|g month:03
|g pages:e2308110
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202308110
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 36
|j 2024
|e 11
|b 15
|c 03
|h e2308110
|